Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,136.61 +425.45 (+0.70%) CMC Crypto 200
1,265.83 -92.18 (-6.79%)
Nabriva Therapeutics plc (NBRVF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 11:44AM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 323.00 |
| Enterprise value | -1.64M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.00 |
| Price/book (mrq) | 0.21 |
| Enterprise value/revenue | -0.09 |
| Enterprise value/EBITDA | 0.07 |
Trading information
Stock price history
| Beta (5Y monthly) | -23.41 |
| 52-week change 3 | -100.00% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 1.9000 |
| 52-week low 3 | 0.0000 |
| 50-day moving average 3 | 0.1059 |
| 200-day moving average 3 | 0.4197 |
Share statistics
| Avg vol (3-month) 3 | 1.58k |
| Avg vol (10-day) 3 | 1.47k |
| Shares outstanding 5 | 3.23M |
| Implied shares outstanding 6 | 3.23M |
| Float 8 | 3.04M |
| % held by insiders 1 | 0.95% |
| % held by institutions 1 | 5.59% |
| Shares short (14 Jul 2023) 4 | 44.59k |
| Short ratio (14 Jul 2023) 4 | 8.58 |
| Short % of float (14 Jul 2023) 4 | 1.39% |
| Short % of shares outstanding (14 Jul 2023) 4 | 1.38% |
| Shares short (prior month 15 Jun 2023) 4 | 35.34k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 03 Dec 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | -186.26% |
| Operating margin (ttm) | -536.07% |
Management effectiveness
| Return on assets (ttm) | -92.85% |
| Return on equity (ttm) | -602.21% |
Income statement
| Revenue (ttm) | 29.56M |
| Revenue per share (ttm) | 9.61 |
| Quarterly revenue growth (yoy) | -75.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -48.53M |
| Net income avi to common (ttm) | -55.05M |
| Diluted EPS (ttm) | -18.3700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.18M |
| Total cash per share (mrq) | 0.68 |
| Total debt (mrq) | 540k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.38 |
| Book value per share (mrq) | -5.05 |
Cash flow statement
| Operating cash flow (ttm) | -12.91M |
| Levered free cash flow (ttm) | 10.81M |
© 2024 Yahoo. All rights reserved.